Matthew Lynn

Pfizer’s Covid vaccine is a victory for the free market

(Photo: Getty)

There are still safety trials to be completed. Data has to be collected, checked, double-checked, and then peer-reviewed. And we still need to find out whether it is the most effective of the various candidates currently in development or whether there is something even better just around the corner. But the Pfizer vaccine has already proved something beyond any reasonable doubt. Free enterprise works. And for all its flaws, it remains the best system for solving complex problems.

Amid all the justifiable excitement over the potential approval of the first safe and effective vaccine against Covid-19 it would be easy to overlook one point: the vaccine was developed with private money. The US government set up Operation Warp Speed to fund lots of different initiatives for finding a scientific way out of this mess. But the American drugs giant decided against taking the money. The reasons were explained by its chief executive Dr Albert Bourla in an interview on American television, and his remarks are worth

Get Britain's best politics newsletters

Register to get The Spectator's insight and opinion straight to your inbox. You can then read two free articles each week.

Already a subscriber? Log in

Written by
Matthew Lynn

Matthew Lynn is a financial columnist and author of ‘Bust: Greece, The Euro and The Sovereign Debt Crisis’ and ‘The Long Depression: The Slump of 2008 to 2031’

Topics in this article

Comments

Join the debate for just $5 for 3 months

Be part of the conversation with other Spectator readers by getting your first three months for $5.

Already a subscriber? Log in